Publication | Open Access

Durable Clinical Response of Lung Adenocarcinoma Harboring EGFR 19Del/T790M/in trans-C797S to Combination Therapy of First- and Third-Generation EGFR Tyrosine Kinase Inhibitors

Durable Clinical ResponseMedicineImmunologyPathologyBronchial NeoplasmCombination TherapyCancer TreatmentCancer GeneticsOncologyLung Cancer